Lewei Pharmaceutical
PrivateLast Round
Series C
Dec 27, 2022
Total Funding Raised
$141.58M
Company Overview
Laviana is a pharmaceutical outsourcing company that specializes in transforming innovative medicine from laboratory to industrial processes, optimizing market-based drug research, and utilizing advanced analytical methods for drug development and testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lewei Pharmaceutical Comparables
Compare Lewei Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bellen Chemistry | 88% | |
| Chongqing Sintaho Pharmaceutical Co., Ltd. | 82% | |
| Sterling Pharma Solutions | 82% |
Lewei Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 27, 2022 | ||||
| Series C | Oct 13, 2021 | ||||
| Series B | Aug 26, 2019 | ||||
| Series B | Jan 2, 2018 | ||||
| Series A | Mar 1, 2014 |
Lewei Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ABC Capital | Series B |
| V-Capital | Series B |
| LYFE Capital | Series B |
| Yingke PE | Series C |
| Huayi Capital | Series B |
| HRVC Capital | Series C |
| HY Capital | Series C |
Lewei Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lewei Pharmaceutical's valuation, stock price, and market status.
Is Lewei Pharmaceutical a public or private company?
Lewei Pharmaceutical is a private company.
What is the current stock price of Lewei Pharmaceutical?
Lewei Pharmaceutical is a private company, so its shares have no public market price. Caplight tracks Lewei Pharmaceutical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lewei Pharmaceutical worth (valuation)?
Valuation information for Lewei Pharmaceutical is not publicly available.
Can I buy Lewei Pharmaceutical stock?
Lewei Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lewei Pharmaceutical's last funding round?
Lewei Pharmaceutical's most recent funding round was Series C on December 27, 2022.
Who are the main investors in Lewei Pharmaceutical?
Key investors in Lewei Pharmaceutical include LYFE Capital, Yingke PE, Huayi Capital.
Will Lewei Pharmaceutical IPO soon?
No public IPO plans have been announced for Lewei Pharmaceutical.
How can I track Lewei Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades in Lewei Pharmaceutical's shares on secondary markets.